Journal of Cancer Therapy
Vol.9 No.1(2018), Paper ID 82015, 13
pages
DOI:10.4236/jct.2018.91006
Detection of the PIK3CA Mutation in Circulating Tumor DNA as a Possible Predictive Indicator for Poor Prognosis of Early-Stage Breast Cancer
Ayaka Sato, Masahiko Tanabe, Yumi Tsuboi, Masako Ikemura, Keiichiro Tada, Yasuyuki Seto, Yoshinori Murakami
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Copyright © 2018 Ayaka Sato, Masahiko Tanabe, Yumi Tsuboi, Masako Ikemura, Keiichiro Tada, Yasuyuki Seto, Yoshinori Murakami et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Sato, A. , Tanabe, M. , Tsuboi, Y. , Ikemura, M. , Tada, K. , Seto, Y. and Murakami, Y. (2018) Detection of the
PIK3CA Mutation in Circulating Tumor DNA as a Possible Predictive Indicator for Poor Prognosis of Early-Stage Breast Cancer.
Journal of Cancer Therapy,
9, 42-54. doi:
10.4236/jct.2018.91006.